Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas

Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas

US Patent 8828381 · Granted Sep 9, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Test system and method with a thermally isolated hollow body inside an over the 2021
Over-the-air test system as well as method for measuring the over-the-air perfor2020
Over-the-air measurement chamber and over-the-air measurement method2019
Refrigerated sales furniture2017
Hybridoma cell line G250 and its use for producing monoclonal antibodies2017
Hybridoma cell line G250 and its use for producing monoclonal antibodies2017
Coaxial plug for connecting to a BNC coaxial socket2011
Adjuvant theraphy of G250-expressing tumors2010
Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal c2009
Co-administration of cG250 and IL-2 or IFN-α for treating cancer such as renal c2009
Method and device for detecting a given material in an object using electromagne2006
Method for image management of X-ray images2004